These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20116035)

  • 1. Response to "A graphic reanalysis of the NINDS Trial".
    Dewey HM; Churilov L; Blacker D; Bladin C; Davis SM; Donnan GA; Gates P; Gerraty RP; Hand P; Levi C; Lindley RI; Markus R; Read S
    Ann Emerg Med; 2010 Feb; 55(2):227-9; author reply 229. PubMed ID: 20116035
    [No Abstract]   [Full Text] [Related]  

  • 2. A graphic reanalysis of the NINDS Trial.
    Hoffman JR; Schriger DL
    Ann Emerg Med; 2009 Sep; 54(3):329-36, 336.e1-35. PubMed ID: 19464756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to: "A graphic reanalysis of the NINDS Trial".
    Saver JL; Gornbein J; Starkman S
    Ann Emerg Med; 2010 Feb; 55(2):226-7; author reply 229. PubMed ID: 20116034
    [No Abstract]   [Full Text] [Related]  

  • 4. A hundred (and one) graphs tell only part of the story.
    Silbergleit R
    Ann Emerg Med; 2009 Sep; 54(3):342-3. PubMed ID: 19695418
    [No Abstract]   [Full Text] [Related]  

  • 5. Stroking the data: re-analysis of the NINDS trial.
    Magid D; Naviaux N; Wears RL
    Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716
    [No Abstract]   [Full Text] [Related]  

  • 6. NINDS Reanalysis Committee's reanalysis of the NINDS trial.
    Mann J
    Stroke; 2005 Feb; 36(2):230-1; author reply 230-1. PubMed ID: 15637327
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis in stroke: still not ready for community hospital use by emergency physicians.
    McNamara RM
    Ann Emerg Med; 2009 Sep; 54(3):339-41. PubMed ID: 19695417
    [No Abstract]   [Full Text] [Related]  

  • 8. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Mann J
    Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
    [No Abstract]   [Full Text] [Related]  

  • 10. Be careful when extrapolating trial data to real life.
    Dudley N
    BMJ; 2003 Oct; 327(7418):812. PubMed ID: 14525900
    [No Abstract]   [Full Text] [Related]  

  • 11. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial.
    LaMonte MP; Bahouth MN; Magder LS; Alcorta RL; Bass RR; Browne BJ; Floccare DJ; Gaasch WR;
    Ann Emerg Med; 2009 Sep; 54(3):319-27. PubMed ID: 19101059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing new ideas: is a picture worth a thousand words?
    Yealy DM; Callaham ML
    Ann Emerg Med; 2009 Sep; 54(3):337-8. PubMed ID: 19695416
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteplase for stroke. Financial information is needed to ensure objectivity.
    Solomon RC
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092607
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolysis for acute stroke: the incontrovertible, the controvertible, and the uncertain.
    Silbergleit R; Scott PA
    Acad Emerg Med; 2005 Apr; 12(4):348-51. PubMed ID: 15805327
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E
    No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.
    Lu M; Lyden PD; Brott TG; Hamilton S; Broderick JP; Grotta JC
    J Neurosci Methods; 2005 Apr; 143(2):209-16. PubMed ID: 15814153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    Whitcomb DS
    Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.